FDA Approved: ESCITALOPRAM OXALATE — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved a supplemental application for escitalopram oxalate from Rising Pharma Holdings, Inc., approving a generic version under the ANDA process.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder
• Major Depressive Disorder

Drugs mentioned

• Escitalopram Oxalate (escitalopram oxalate)

Snippet

SUPPL AP for ESCITALOPRAM OXALATE (ESCITALOPRAM OXALATE)